$Celularity (CELU.US)$ NEWS Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy Celularity (NASDAQ: CELU) has announced that data published in the Journal for ImmunoTherapy of Cancer highlights the benefits of its placental-derived T-Cell platform for CAR-T therapies. The study revealed that CAR-T cells from Celularity's platform demonstrated greater persistence, resistance to exhaustion, and efficacy compared to tho...
Celularity股票讨论
NEWS
Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
Celularity (NASDAQ: CELU) has announced that data published in the Journal for ImmunoTherapy of Cancer highlights the benefits of its placental-derived T-Cell platform for CAR-T therapies. The study revealed that CAR-T cells from Celularity's platform demonstrated greater persistence, resistance to exhaustion, and efficacy compared to tho...
本辛加· 2 分钟前
本辛加· 1 分钟前
$Taysha Gene Therapies (TSHA.US)$ 2023 财年业绩为 21%
$TFF Pharmaceuticals (TFFP.US)$ 14% 临床项目更新
$Jaguar Health (JAGX.US)$ 14% Crofelemer 商业化
$Acelyrin (SLRN.US)$ 4% Ph1/2 阳性数据
$迪卡斯 (DCTH.US)$ 3% 完成700万美元私募配售
$Sellas Life Sciences (SLS.US)$ 0% 完成2000万美元发行和私募配售
$Immunic (IMUX.US)$ 1% 专利许可通知
$Nurix Therapeutics (NRIX.US)$ 0...
暂无评论